GlassScriptPhysician profile
Gary Shelton
NPI 1467581348
$1,248.48
in general payments reported to CMS, 2019-2025
16 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $60.96 · 2021: $44.21 · 2022: $189 · 2023: $162 · 2024: $228 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $284.30 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $270.68 | 2019-2025 | Shingrix, Arexvy, Flulaval Quadrivalent |
| Amgen INC. | $254.85 | 2019-2025 | Evenity |
| Gilead Sciences, INC. | $129.75 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $48.57 | 2022 | |
| Abbvie INC. | $45.06 | 2022-2023 | Vraylar |
| Hologic Sales and Service, LLC | $36.87 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Sunovion Pharmaceuticals INC. | $32.30 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.03 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $24.85 | 2019-2021 | |
| Boston Scientific Corporation | $19.54 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.04 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.15 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.89 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Shelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.